Association of Interleukin-6 Gene Polymorphisms with Bone Mineral Density in Mexican Women

Archives of Medical Research

Volumn 39, Issue 6, 2008, Pages 618-624

  Magaña, Jonathan J ^a,b   Gómez, Rocío ^a   Cisneros, Bulmaro ^b   Casas, Leonora ^a   Valdés Flores, Margarita ^a  

^a National Institute of Rehabilitation   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Bone mineral density; Dinucleotide polymorphism; Interleukin 6 gene; Osteoporosis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 6;

ADULT; ALLELE; ARTICLE; BONE DENSITY; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DISEASE MARKER; DNA POLYMORPHISM; ENZYME ASSAY; FEMALE; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MEXICO; OSTEOPOROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

BASE SEQUENCE; BONE DENSITY; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENETIC MARKERS; HUMANS; INTERLEUKIN-6; MEXICO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 47749104489     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.05.006     Document Type: Article

References (38)

1. Melton III L.J., Chrischilles E.A., Cooper C., Lane A.W., and Riggs B.L. Perspective, how many women have osteoporosis?. J Bone Miner Res 7 (1992) 1005-1010
2. Anon. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94 (1993) 646-650
3. Melton III L.J. Epidemiology worldwide. Endocrinol Metab Clin North Am 32 (2003) 1-13
4. Flicker L., Hopper J.L., Rodgers L., Kaymakci B., Green R.M., and Wark J.D. Bone density determinants in elderly women: a twin study. J Bone Miner Res 10 (1995) 1607-1613
5. Stewart T.L., and Ralston S.H. Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166 (2000) 235-245
6. Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., and Johnston C.C. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 6 (1991) 561-567
7. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., et al. Prediction of bone density from vitamin D receptor alleles. Nature 367 (1994) 284-287
8. Magaña J.J., Gómez R., Cisneros B., Casas L., Castorena F., Miranda A., et al. Association of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican women. Clin Genet 70 (2006) 402-408
9. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., and Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11 (1996) 306-311
10. Ogawa S., Hosoi T., Shiraki M., Orimo H., Emi M., Muramatsu M., et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 269 (2000) 537-541
11. Grant S.F., Reid D.M., Blake G., Herd R., Fogelman I., and Ralston S.H. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 14 (1996) 203-205
12. Shiraki M., Shiraki Y., Aoki C., Hosoi T., Inoue S., Kaneki M., et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12 (1997) 1438-1445
13. Langdahl B.L., Knudsen J.Y., Jensen H.K., Gregersen N., and Eriksen E.F. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20 (1997) 289-294
14. Hosoi T., Miyao M., Inoue S., Hoshino S., Shiraki M., Orimo H., et al. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 64 (1999) 205-208
15. Murray R.E., McGuigan F., Grant S.F., Reid D.M., and Ralston S.H. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21 (1997) 89-92
16. Zajickova K., and Zofkova I. Osteoporosis: genetic analysis of multifactorial disease. Endocr Regul 37 (2003) 31-44
17. Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16 (1998) 249-284
18. Manolagas S.C., Bellido T., and Jilka R.L. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL6 and gp130. Int J Immunopharmacol 17 (1995) 109-116
19. Poli G., Kinter A.L., and Fausi A.S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 91 (1994) 108-112
20. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9 (1994) 883-890
21. Tsukamoto K., Yoshida H., Watanabe S., Suzuki T., Miyao M., Hosoi T., et al. Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women. J Hum Genet 44 (1999) 148-151
22. Takacs I., Koller D.L., Peacock M., Christian J.C., Evans W.E., Hui S.L., et al. Sib pair linkage and association studies between bone mineral density and the interleukin 6 gene locus. Bone 27 (2000) 169-173
23. Huang Q.Y., Shen H., Deng H.Y., Conway T., Davies K.M., Li J.L., et al. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J Hum Genet 48 (2003) 430-437
24. Lorentzon M., Lorentzon R., and Nordstrom P. Interleukin 6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res 15 (2000) 1944-1949
25. Ferrari S.L., Garnero P., Emond S., Montgomery H., Humphries S.E., and Greenspan S.L. Two polymorphisms regulating interleukin 6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 255-259
26. Moffett S.P., Zmuda J.M., Cauley J.A., Stone K.L., Nevitt M.C., Ensrud K., et al. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res 19 (2004) 1612-1618
27. Garnero P., Borel O., Sornay-Rendu E., Duboeuf F., Jeffery R., Woo P., et al. Association between a functional interleukin 6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. Bone 31 (2002) 43-50
28. Chung H.W., Seo J.S., Hur S.E., Kim H.L., Kim J.Y., Jung J.H., et al. Association of interleukin 6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 48 (2003) 243-248
29. Gómez R., Magaña J.J., Cisneros B., Pérez-Salazar E., Faugeron S., Véliz D., et al. Association of the estrogen receptor α gene polymorphisms with Osteoporosis in the Mexican population. Clin Genet 72 (2007) 574-581
30. Pritchard J.K., Stephens M., Rosenberg N.A., and Donelly P. Association mapping in structured populations. Am J Hum Genet 67 (2000) 170-181
31. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, New York
32. Pritchard J.K., and Rosenberg N.A. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65 (1999) 220-228
33. Rousset F., and Raymond M. Testing heterozygote excess and deficiency. Genetics 140 (1995) 1413-1419
34. Tang H., Quertermous T., Rodriguez B., Kardia S.L., Zhu X., Brown A., et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 76 (2005) 268-275
35. Clayton D.G., Walker N.M., Smyth D.J., Pask R., Cooper J.D., Maier L.M., et al. Population structure, differential bias and genomic control in large-scale, case-control association study. Nat Genet 37 (2005) 1243-1246
36. Hoggart C.J., Parra E.J., Shriver M.D., Kittles R.A., Clayton D.G., and McKeigue P.M. Control of confounding of genetics in stratified populations. Am J Hum Genet 72 (2003) 1492-1504
37. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
38. Ferry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144